Parallel Advisors, LLC - QIAGEN NV ownership

QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 281 filers reported holding QIAGEN NV in Q1 2023. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of QIAGEN NV
ValueSharesWeighting
Q3 2023$20,817
+17.9%
514
+31.1%
0.00%0.0%
Q2 2023$17,652
+6.2%
392
+8.3%
0.00%0.0%
Q1 2023$16,627
+10.0%
362
+19.5%
0.00%0.0%
Q4 2022$15,111
+7.9%
303
-8.7%
0.00%0.0%
Q3 2022$14,000
-12.5%
332
-1.2%
0.00%0.0%
Q2 2022$16,000
-33.3%
336
-30.0%
0.00%0.0%
Q1 2022$24,000
-20.0%
480
-10.1%
0.00%0.0%
Q4 2021$30,000
+25.0%
534
+17.1%
0.00%0.0%
Q3 2021$24,000
+9.1%
456
+1.1%
0.00%0.0%
Q2 2021$22,000
-26.7%
451
-27.6%
0.00%0.0%
Q1 2021$30,000
-6.2%
623
+1.6%
0.00%
-50.0%
Q4 2020$32,000
+18.5%
613
+19.5%
0.00%0.0%
Q3 2020$27,000
+28.6%
513
+3.4%
0.00%
+100.0%
Q2 2020$21,000
-87.4%
496
-87.7%
0.00%
-92.9%
Q1 2020$167,000
+24.6%
4,030
+1.7%
0.01%
+40.0%
Q4 2019$134,0000.0%3,962
-2.2%
0.01%
-9.1%
Q3 2019$134,000
-17.3%
4,051
+1.6%
0.01%
-31.2%
Q2 2019$162,000
+23.7%
3,987
+24.2%
0.02%
+6.7%
Q1 2019$131,000
+19.1%
3,2100.0%0.02%0.0%
Q4 2018$110,000
-9.8%
3,2100.0%0.02%0.0%
Q3 2018$122,000
+617.6%
3,210
+548.5%
0.02%
+650.0%
Q2 2018$17,000
-37.0%
495
-40.9%
0.00%
-50.0%
Q1 2018$27,000
+3.8%
8380.0%0.00%0.0%
Q4 2017$26,000
-13.3%
838
-12.6%
0.00%
-20.0%
Q3 2017$30,0000.0%959
+5.8%
0.01%
-16.7%
Q2 2017$30,000
+7.1%
906
-1.9%
0.01%
+100.0%
Q1 2017$28,0009240.00%
Other shareholders
QIAGEN NV shareholders Q1 2023
NameSharesValueWeighting ↓
Varenne Capital Partners 607,000$24,588,83923.75%
SYCOMORE ASSET MANAGEMENT 428,513$16,8664.32%
Nekton Capital Ltd. 614,940$24,905,0703.95%
Grandeur Peak Global Advisors, LLC 847,699$34,331,8102.58%
Southpoint Capital Advisors LP 1,500,000$60,750,0001.36%
Point72 Europe (London) LLP 468,364$18,968,7421.16%
SECTOR GAMMA AS 100,713$4,078,8771.04%
Susquehanna International Securities, Ltd. 28,711$1,162,7960.98%
Bank of Italy 651,125$26,3990.84%
PDT Partners, LLC 123,216$4,990,2480.63%
View complete list of QIAGEN NV shareholders